Up to 27 Percent Endometrioma Recurrence Rate Detected in absence of Post-Surgical Hormonal Therapy: Study
Netherlands: A comprehensive systematic review and meta-analysis have provided new insights into the recurrence rates following surgery for endometriomas, a common and challenging form of endometriosis. The study, published in Fertility and Sterility, aims to clarify the likelihood of endometrioma recurrence and identify factors influencing surgical outcomes.
The meta-analysis revealed that endometrioma recurrence rates after surgery can reach up to 27% by 24 months, especially among women who do not use postoperative hormonal therapy. The study documented recurrence rates of 4% at three months, 14% at six months, 17% at 12 months, and 27% at 24 months, highlighting the persistent challenge of managing endometriomas without hormonal treatment.
Endometriomas are ovarian cysts filled with old blood that result from endometriosis, a condition where tissue similar to the lining of the uterus grows outside it. These endometriomas can, in addition to medical treatment, be treated surgically. After surgery, hormonal therapy is still frequently used for the treatment of endometriosis in general and the prevention of the recurrence of endometriomas specifically. However, not all women want or can receive postoperative hormonal treatment. This group needs to know the risk of anatomical recurrence of ovarian endometrioma after surgery for an endometrioma.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.